In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Endo Pharma buys HealthTronics for $221mm in cash

Executive Summary

Endo Pharmaceuticals Holdings Inc. (mainly neurology and urology drugs) has agreed to buy publicly traded HealthTronics Inc. (urology treatments and anatomical pathology services) for $221mm, plus the assumption of $35mm in debt. Shareholders will receive $4.85 per share (a 41% premium) in cash.
Deal Industry
  • Laboratory Testing Services
  • Medical Devices
  • Medical Devices
    • Laser
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies